Cosmos Study Published in the New England Journal of Medicine
June 17, 2023 - New England Journal Of Medicine
Using Cosmos data, Epic Research and the CDC co-published new research on the effectiveness of the mpox vaccine in the New England Journal of Medicine.
Since mpox is a rare disease, studying it required a large, diverse database, and the size, representativeness, and recency of Cosmos data allowed the researchers to provide timely insights during a public health emergency. The results show that 2 out of 3 mpox cases can be prevented with full vaccination against mpox and this information was so important that the CDC received special permission to publish the preliminary findings online in December 2022.
This is new medical knowledge that directly impacts patient care and shows how our Cosmos participating organizations are helping to advance research and evidence-based medicine around the world.
A Conversation with Borno Akhter on Building Technology That Helps Patients
October 12, 2026
Epic’s Hello World development lead discusses immersion trips, earning patient trust over text and voice, and helping patients get what they need—however they prefer to communicate.
Memorial Hermann Health System Clinicians Use Epic’s AI Tool to Help Patients Better Understand Test Results
September 8, 2026
Clinicians at Memorial Hermann Health System (MHHS) are using a new artificial intelligence (AI) tool built directly into Epic to help patients better understand their test results and to make informed decisions about next steps in their care journey.
